• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.

作者信息

Webb Gwilym J, Moon Andrew M, Barnes Eleanor, Barritt A Sidney, Marjot Thomas

机构信息

Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.

出版信息

J Hepatol. 2021 Jul;75(1):226-228. doi: 10.1016/j.jhep.2021.01.036. Epub 2021 Feb 5.

DOI:10.1016/j.jhep.2021.01.036
PMID:33556419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7863751/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7863751/8e877618db71/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7863751/8e877618db71/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7863751/8e877618db71/gr1_lrg.jpg

相似文献

1
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.年龄和合并症是肝移植受者因 COVID-19 死亡风险的核心因素。
J Hepatol. 2021 Jul;75(1):226-228. doi: 10.1016/j.jhep.2021.01.036. Epub 2021 Feb 5.
2
Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry.新冠疫情对欧洲肝移植的影响：来自欧洲肝脏和肠道移植协会及欧洲肝移植登记处的早期调查警报。
Transpl Int. 2020 Oct;33(10):1244-1252. doi: 10.1111/tri.13680. Epub 2020 Aug 13.
3
Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients".回复：“年龄和合并症是肝移植受者死于COVID-19风险的关键因素”。
J Hepatol. 2021 Jul;75(1):228-229. doi: 10.1016/j.jhep.2021.04.005. Epub 2021 Apr 20.
4
Liver transplant outcomes during the COVID-19 pandemic.新冠疫情期间的肝移植结果
Ann Hepatol. 2022 Mar-Apr;27(2):100656. doi: 10.1016/j.aohep.2021.100656. Epub 2021 Dec 23.
5
SARS-CoV-2 infection in liver transplant recipients: A complex relationship.肝移植受者的 SARS-CoV-2 感染：一种复杂的关系。
World J Gastroenterol. 2021 Nov 28;27(44):7734-7738. doi: 10.3748/wjg.v27.i44.7734.
6
Outcomes of Coronavirus Disease 2019 in Living Donor Liver Transplant Recipients.活体肝移植受者中2019冠状病毒病的结局
Liver Transpl. 2020 Dec;26(12):1665-1666. doi: 10.1002/lt.25909. Epub 2020 Nov 5.
7
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
8
Between fear and courage: Attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic.在恐惧与勇气之间：COVID-19 大流行期间肝移植受者和候补名单患者的态度、信念和行为。
Am J Transplant. 2020 Nov;20(11):3042-3050. doi: 10.1111/ajt.16118. Epub 2020 Jun 27.
9
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.肝移植受者与免疫功能正常患者感染 SARS-CoV-2 后体液免疫应答的变化。
Am J Transplant. 2021 Aug;21(8):2876-2884. doi: 10.1111/ajt.16599. Epub 2021 Apr 27.
10
COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation.COVID-19 感染在实体器官移植受者中的情况：移植后即刻患者的单中心经验。
Transpl Infect Dis. 2021 Feb;23(1):e13381. doi: 10.1111/tid.13381. Epub 2020 Jul 6.

引用本文的文献

1
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients.肝移植受者接种XBB.1.5加强针后对SARS-CoV-2 XBB.1.5和JN.1变体的免疫反应
Viruses. 2024 Dec 19;16(12):1942. doi: 10.3390/v16121942.
2
Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients.未接种疫苗的实体器官移植受者中 SARS-CoV-2 感染和重症 COVID-19 的风险因素。
Sci Rep. 2024 Nov 2;14(1):26465. doi: 10.1038/s41598-024-78119-6.
3
Clinical and Genomic Perspective of SARS CoV-2 Infection in Liver Disease Patients: A Single-Centre Retrospective Study.

本文引用的文献

1
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性：系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
2
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
3
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.
肝脏疾病患者中严重急性呼吸综合征冠状病毒 2 感染的临床和基因组观点：一项单中心回顾性研究。
Curr Microbiol. 2024 Aug 8;81(9):301. doi: 10.1007/s00284-024-03786-7.
4
Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.COVID-19 疫苗接种对肝移植受者的影响。墨西哥一个参考中心的经验。
PLoS One. 2024 Mar 28;19(3):e0301198. doi: 10.1371/journal.pone.0301198. eCollection 2024.
5
COVID-19 infection in liver transplant recipients: Clinical features and outcomes from a Canadian multicentre cohort.肝移植受者中的新型冠状病毒肺炎感染：来自加拿大多中心队列的临床特征与结局
Can Liver J. 2022 Nov 7;5(4):507-512. doi: 10.3138/canlivj-2022-0015. eCollection 2022 Nov.
6
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave.奥密克戎变异株流行期间肝移植受者感染 SARS-CoV-2 的临床转归
Viruses. 2023 Jan 20;15(2):297. doi: 10.3390/v15020297.
7
Challenges in liver transplantation in the context of a major pandemic.重大疫情背景下肝移植面临的挑战。
World J Transplant. 2022 Nov 18;12(11):347-358. doi: 10.5500/wjt.v12.i11.347.
8
A real-world experience of SARS-CoV-2 infection in a tertiary referral centre of Montréal: Unexpected low prevalence and low mortality.蒙特利尔一家三级转诊中心的新型冠状病毒肺炎感染真实世界经验：意外的低患病率和低死亡率
Can Liver J. 2021 Nov 11;4(4):391-400. doi: 10.3138/canlivj-2021-0022. eCollection 2021 Fall.
9
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.COVID-19 对肝脏的影响以及对慢性肝病、肝胆癌和肝移植患者的治疗影响：EASL 最新立场文件。
J Hepatol. 2022 Oct;77(4):1161-1197. doi: 10.1016/j.jhep.2022.07.008. Epub 2022 Jul 20.
10
SARS-CoV-2 infection and liver involvement.严重急性呼吸综合征冠状病毒 2 感染与肝脏受累。
Hepatol Int. 2022 Aug;16(4):755-774. doi: 10.1007/s12072-022-10364-1. Epub 2022 Jun 29.
肝移植患者 COVID-19 的流行病学模式、发病率和结局。
J Hepatol. 2021 Jan;74(1):148-155. doi: 10.1016/j.jhep.2020.07.040. Epub 2020 Aug 1.
4
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.纵向研究中预后合并症分类的一种新方法：开发与验证
J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.